Walgreens Inks $105M Deal To End Investor Suit Over Merger
Pharmacy chain Walgreens and two of its former executives have agreed to pay $105 million to end investor claims the company touted overly rosy financial projections as it sought shareholder approval...To view the full article, register now.
Already a subscriber? Click here to view full article